← Open Payments lookup

ZACHARY WHITTLE: Open Payments

NPI 1508492570 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,111 in 127 payments from 32 companies in 2025. Trend: 2023 $1,860 · 2024 $1,911 · 2025 $2,111

Food & beverage: $2,092Education: $19
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$271
ABBVIE INC.20$270
GlaxoSmithKline, LLC.19$248
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$226
Novo Nordisk Inc10$145
Amgen Inc.8$119
E.R. Squibb & Sons, L.L.C.3$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$66
Teva Pharmaceuticals USA, Inc.3$48
Neurocrine BioSciences, Inc.2$45

Products named: REXULTI, CAPLYTA, TRELEGY ELLIPTA, VRAYLAR, OTEZLA, Ozempic, COBENFY, XIFAXAN.

Industry payments across MI — which companies pay providers there.